Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00753779 · ClinicalTrials.gov registry record · Phase 4
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.
A Phase 4 study of Hypercholesterolemia, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
- 14
- Study locations
NCT00753779: Completed Phase 4 study of Hypercholesterolemia, sponsored by Daiichi Sankyo.
NCT00753779 is a Phase 4 study of Hypercholesterolemia that has completed, run by Daiichi Sankyo. The registered enrollment target is 72 participants, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (91% lower). The trial reports 14 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00753779, a Phase 4 study of Hypercholesterolemia, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
- 14
- Study locations
Study Summary
The primary objective is to determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on simvastatin therapy for at least 4 weeks.
Conditions Studied
Interventions
- DRUG colesevelam HCl tablets, and simvastatin tablets
- DRUG simvastatin tablets and colesevelam HCl placebo
Study Locations (14)
Florida
- - Jacksonville
- - Pembroke Pines
- - St. Petersburg
Ohio
- - Cincinnati
- - Cleveland
Virginia
- - Norfolk
- - Richmond
California
- - Los Angeles
Colorado
- - Castle Rock
Illinois
- - Chicago
Indiana
- - Indianapolis
New York
- - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
What the finished NCT00753779 record still lists
NCT00753779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which colesevelam HCl tablets, and simvastatin tablets is the first listed.
NCT00753779 lists 14 locations in 10 states (Florida, Ohio, Virginia).
Frequently Asked Questions
What is clinical trial NCT00753779 about?
NCT00753779 is a clinical study titled "A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.". The primary objective is to determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on simvastatin therapy for at least 4 weeks.
What is the current status of trial NCT00753779?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2002-11. Estimated completion is 2005-04.
What conditions does trial NCT00753779 study?
This clinical trial studies the following conditions: Hypercholesterolemia.
What interventions are being tested in trial NCT00753779?
The interventions under investigation include: colesevelam HCl tablets, and simvastatin tablets (DRUG), simvastatin tablets and colesevelam HCl placebo (DRUG).
Who is sponsoring clinical trial NCT00753779?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00753779 being conducted?
This trial has 14 study locations across California, Colorado, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00753779's enrollment target sits among peer trials
72 46th of 62 higher than 16 of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
COMPLETED · Phase 4
-
Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
COMPLETED · Phase 4
-
Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
COMPLETED · Phase 4
-
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
COMPLETED · Phase 4
-
Cholesterol and Pharmacogenetic Study
COMPLETED · Phase 4
-
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia